Samsung Epis Holdings Co Ltd Sustainability Reports
Serves as an investment holding company specializing in the management of biopharmaceutical portfolios and biotechnology subsidiaries, including the research and development of biosimilar medicines.
Sector: Manufacturing
Country: South Korea
Exchange: Korea Exchange (KOSPI)
FIGI: BBG01V5FHRT2
1 reports from 2025 to 2025